| P50 | author | Aristi P. Fernandes | Q37610348 |
| P2093 | author name string | Mikael Björnstedt | |
| P2860 | cites work | Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine | Q24806411 |
| | Characterization of mammalian selenoproteomes. | Q27863319 |
| | From selenium to selenoproteins: synthesis, identity, and their role in human health | Q27863358 |
| | Protection against reactive oxygen species by selenoproteins | Q27863399 |
| | Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress | Q28260210 |
| | Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen | Q28627251 |
| | Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase | Q28627372 |
| | Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29619860 |
| | Molecular chemoprevention by selenium: a genomic approach | Q30796187 |
| | Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer | Q31158946 |
| | Selenoproteins and human health: insights from epidemiological data | Q33423296 |
| | Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis | Q33982039 |
| | Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer Cells | Q34276889 |
| | Evolution of selenocysteine-containing proteins: significance of identification and functional characterization of selenoproteins. | Q34377761 |
| | The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology | Q34965687 |
| | Selenium and its relationship to cancer: an update | Q35641512 |
| | The thioredoxin system in cancer | Q36648323 |
| | Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis | Q37049739 |
| | Extracellular thiol-assisted selenium uptake dependent on the x(c)- cystine transporter explains the cancer-specific cytotoxicity of selenite. | Q37256851 |
| | Selenium and anticarcinogenesis: underlying mechanisms | Q37283275 |
| | Selenoproteins that function in cancer prevention and promotion | Q37392209 |
| | Potential stages for prostate cancer prevention with selenium: implications for cancer survivors | Q37422830 |
| | Selenium and selenium-antagonistic elements in nutritional cancer prevention | Q37514214 |
| | Selenium and the selenoprotein thioredoxin reductase in the prevention, treatment and diagnostics of cancer. | Q37600881 |
| | Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays | Q38292277 |
| | Cancer mortality correlation studies--III: statistical associations with dietary selenium intakes | Q38564567 |
| | Selenium compounds are substrates for glutaredoxins: a novel pathway for selenium metabolism and a potential mechanism for selenium-mediated cytotoxicity | Q39712375 |
| | Serum selenium level and prostate cancer: a case-control study | Q39844631 |
| | The JNK signaling pathway is involved in sodium-selenite-induced apoptosis mediated by reactive oxygen in HepG2 cells | Q39946948 |
| | Selenium distribution and human cancer mortality | Q40009725 |
| | Induction of phase II enzyme activity by various selenium compounds. | Q40219710 |
| | Monomethyl selenium--specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation | Q40828475 |
| | Effect of dietary supplementation of selenite on pulmonary metastasis of melanoma cells in mice | Q42443986 |
| | Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. | Q42528232 |
| | Organic and inorganic selenium compounds produce different protein patterns in the blood plasma of rats | Q43278191 |
| | Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: implications for the anticarcinogenic activity of L-selenomethionine and L-Se-methylselenocysteine | Q43859754 |
| | The nutritional prevention of cancer: 400 mcg per day selenium treatment | Q44134098 |
| | Selenium in breast cancer. | Q44405283 |
| | Methylation and demethylation of intermediates selenide and methylselenol in the metabolism of selenium | Q45345692 |
| | Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong | Q45762995 |
| | Cancer chemoprevention: selenium as a prooxidant, not an antioxidant | Q45844552 |
| | Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells. | Q46005478 |
| | Selenium metabolism in rats with long-term ingestion of Se-methylselenocysteine using enriched stable isotopes. | Q46066401 |
| | Redox regulation of NF-kappa B activation | Q46098446 |
| | Oxidation of glutathione and superoxide generation by inorganic and organic selenium compounds | Q46355068 |
| | Decreased glutathione levels potentiate the apoptotic efficacy of selenium: possible involvement of p38 and JNK MAPKs--in vitro studies | Q46909405 |
| | Effect of micronutrients, antioxidants and related compounds on the mutagenicity of 3,2′-dimethyl-4-aminobiphenyl, a colon and breast carcinogen | Q50211713 |
| | Selenocysteine beta-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide | Q50336050 |
| | Selenium prevents tumor development in a rat model for chemical carcinogenesis. | Q53364455 |
| | A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China | Q67714945 |
| | Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase | Q68761452 |
| | Mercury, silver, and gold inhibition of selenium-accelerated cysteine oxidation | Q69622179 |
| | Influence of dietary methionine on the metabolism of selenomethionine in rats | Q69667495 |
| | Selenium protection against testicular lipid peroxidation from cadmium | Q70736469 |
| | Comparison of the chemical properties of selenocysteine and selenocystine with their sulfur analogs | Q72358078 |
| | Selenotrisulfides. II. Cross-linking of reduced pancreatic ribonuclease with selenium | Q72519041 |
| | Prediagnostic serum selenium and risk of cancer | Q72556164 |
| | Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia | Q73093217 |
| | Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial | Q73280460 |
| | Effect of dietary copper on selenium toxicity in Fischer 344 rats | Q73503557 |
| | Inhibitory effect of selenite on invasion of HT1080 tumor cells | Q73684890 |
| | Speciation and bioavailability of selenium in yeast-based intervention agents used in cancer chemoprevention studies | Q79925487 |
| | Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action | Q80159176 |
| | Discovery of biomarkers that reflect the intake of sodium selenate by nutritional proteomics | Q84737804 |
| P433 | issue | 3 | |
| P304 | page(s) | 389-395 | |
| P577 | publication date | 2010-06-29 | |
| P1433 | published in | The EPMA journal | Q26842213 |
| P1476 | title | Selenium in the prevention of human cancers | |
| P478 | volume | 1 | |